Back to Agenda
ICMRA, the hub of international collaboration on COVID-19’
Session Chair(s)
Guido Rasi, MD
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology
Tor Vergata University of Rome, Italy
The session is an opportunity to showcase what ICMRA has been doing on COVID-19. ICMRA has led the international collaboration towards regulatory convergence, sharing of experience and support to fast track procedures and regulatory flexibility. ICMRA has held technical meetings on vaccines and other therapeutics, trials, and observational studies, and communicated widely on the engagement of regulators in the fight against COVID-19. The Coalition meets every other week to discuss policies, regulatory flexibility and shortages. The panel will share with the audience their experience of COVID-19 and answer questions on the progress to date.
Learning Objective : increase Awareness of ICMRA leadership and activities (past and future) related to COVID-19
Speaker(s)
Overview
Marco Cavaleri, PhD
European Medicines Agency, Netherlands
Head of Health Threats and Vaccines Strategy
Panelist
Yasuhiro Fujiwara, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Panelist
John Skerritt, PhD
University of Melbourne, Australia
Enterprise Professor, Health Research Impact
Panelist
Nicola Magrini
Italian Medicines Agency-AIFA , Italy
General Director
Have an account?